Neuropeptide S vs Xenopsin — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
Neuropeptide S (NPS) is a 20-amino acid peptide discovered in 2004 that acts on the NPS receptor (NPSR1), a Gq/Gs-coupled GPCR with highest expression in amygdala, hypothalamus, and brainstem arousal centers. NPS produces a distinctive combination of simultaneous wakefulness prom...
Calculate Neuropeptide S dose →Xenopsin is an octapeptide originally isolated from the skin of the South African clawed frog Xenopus laevis. It shares structural similarity with the C-terminal portion of neurotensin and activates neurotensin receptors....
Calculate Xenopsin dose →| Parameter | Neuropeptide S | Xenopsin |
|---|---|---|
| Category | Neuropeptide | Neuropeptide |
| Research | Preclinical | Preclinical |
| Half-Life | Short (minutes, CNS) | Short |
| Typical Dose | 0.1-10 nmol (ICV, animal) | N/A (research) |
| Frequency | Variable | N/A |
| Route | Intracerebroventricular (animal research) | IV / ICV (research) |
| FDA Status | Not approved | Not approved |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.